Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection

<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	Oxford University Press 2019

Antzeko izenburuak

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
nork: Wang, Y, et al.
Argitaratua: (2020)

Does Oseltamivir Really Reduce Complications of Influenza?
nork: Del Mar, C, et al.
Argitaratua: (2011)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
nork: Chairat, K, et al.
Argitaratua: (2016)

Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
nork: Lee, J, et al.
Argitaratua: (2020)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
nork: Instiaty, I, et al.
Argitaratua: (2013)

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
nork: Butler, CC, et al.
Argitaratua: (2019)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
nork: Le, Q, et al.
Argitaratua: (2010)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
nork: Mai, L, et al.
Argitaratua: (2010)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
nork: Seo, S, et al.
Argitaratua: (2013)

Oseltamivir resistance in influenza A (H5N1) infection - Reply
nork: Jong, d, et al.
Argitaratua: (2006)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
nork: Wattanagoon, Y, et al.
Argitaratua: (2009)

Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial.
nork: Network, S
Argitaratua: (2013)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
nork: Jong, d, et al.
Argitaratua: (2005)

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
nork: Jefferson, T, et al.
Argitaratua: (2014)

Why don't we have all the evidence on oseltamivir?
nork: Godlee, F, et al.
Argitaratua: (2009)

Importance of collection tube during clinical studies of oseltamivir.
nork: Lindegardh, N, et al.
Argitaratua: (2007)

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
nork: Taylor, W, et al.
Argitaratua: (2008)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
nork: Lindegårdh, N, et al.
Argitaratua: (2007)

Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial
nork: South East Asia Infectious Disease Clinical Research Network,
Argitaratua: (2013)

Molecular Dynamics Studies Of The Effects Of Neuraminidase Mutation On Oseltamivir Resistance
nork: Muhammad Yusuf, Muhammad Yusuf
Argitaratua: (2015)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
nork: Lindegardh, N, et al.
Argitaratua: (2006)

Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
nork: Hurt, A, et al.
Argitaratua: (2010)

Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
nork: Nakamura, K, et al.
Argitaratua: (2010)

Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.
nork: Seale, A, et al.
Argitaratua: (2011)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
nork: Jittamala, P, et al.
Argitaratua: (2014)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
nork: Jittamala, P, et al.
Argitaratua: (2014)

Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
nork: Jefferson, T, et al.
Argitaratua: (2014)

Direct and indirect costs of influenza-like illness treated with and without oseltamivir in 15 European countries: a descriptive analysis alongside the randomised controlled ALIC4E trial
nork: Li, X, et al.
Argitaratua: (2021)

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia
nork: Hurt, A. C., et al.
Argitaratua: (2013)

A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir.
nork: Herxheimer, A, et al.
Argitaratua: (2009)

Comparative outcomes of adults hospitalized with seasonal influenza A or B virus infection: application of the 7-category ordinal scale
nork: Wang, Y, et al.
Argitaratua: (2019)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.
nork: Anekthananon, T, et al.
Argitaratua: (2013)

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
nork: Butler, Jeff, et al.
Argitaratua: (2014)

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China
nork: Yu, H, et al.
Argitaratua: (2010)

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
nork: Yu, H, et al.
Argitaratua: (2010)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
nork: Pukrittayakamee, S, et al.
Argitaratua: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
nork: Pukrittayakamee, S, et al.
Argitaratua: (2011)

Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19)
nork: Aliyu, Basiru, et al.
Argitaratua: (2022)

Mutations I117V and I117M and Oseltamivir sensitivity of pandemic (H1N1) 2009 viruses
nork: Hurt, Aeron, et al.
Argitaratua: (2013)

Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
nork: Taylor, P, et al.
Argitaratua: (2022)